Persons with dispensed medicines; origin

Persons with dispensed medicines; origin

Sex Age Origin Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A Alimentary tract and metabolism 2024* 14.03
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A02B Drugs for peptic ulcer and gord 2024* 6.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A03B Belladonna and derivatives, plain 2024* 0.02
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A03E Antispasmodics and anticholinergics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A04 Antiemetics and antinauseants 2024* 0.75
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A04A Antiemetics and antinauseants 2024* 0.75
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A05 Bile and liver therapy 2024* 0.08
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A05C Bile therapy drugs and lipotropics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A10A Insulins and analogues 2024* 0.86
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A11C Vit A and D, incl.combin.of the two 2024* 0.07
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A11D Vitamin B1,and with vit. B6 and B12 2024* 0.01
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands A16A Oth.aliment.tract and metabol.prod. 2024* 0.02
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands B Blood and blood forming organs 2024* 6.48
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands B02B Vitamin k and other hemostatics 2024* 0.03
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands B03B Vitamin B12 and folic acid 2024* 1.19
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands B05A Blood and related products 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands B05Z Hemodialytics and hemofiltrates 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands C01B Antiarrhythmics, class I and III 2024* 0.14
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands C07B Beta blocking agents and thiazides 2024* 0.02
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands D02 Emollients and protectives 2024* 5.62
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands D02A Emollients and protectives 2024* 5.62
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands D08 Antiseptics and disinfectants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands D08A Antiseptics and disinfectants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands G Genito urinary system and sex hormones 2024* 6.06
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands G03B Androgens 2024* 0.17
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands G03E Androgens / female sex hormon.comb. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands G03H Antiandrogens 2024* 0.01
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands H05A Parathyroid hormones and analogues 2024* 0.01
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands J01E Sulfonamides and trimethoprim 2024* 0.59
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands J06 Immune sera and immunoglobulins 2024* 0.05
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands J07C Bacterial and viral vaccines,combi. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands L Antineoplastic and immunomodul. agents 2024* 1.35
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands L01F Monoclonal antbodies and a.d.c. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands L02A Hormones and related agents 2024* 0.11
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands M02A Joint and muscular pain top. prod. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands M05B Bone structure and mineralization . 2024* 0.36
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands N02B Other analgesics and antipyretics 2024* 0.75
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands N05C Hypnotics and sedatives 2024* 0.86
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands P01C Leishmaniasis and trypanosomiasis 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands P03B Insecticides and repellents 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands R05 Cough and cold preparations 2024* 2.27
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands R05F Cough suppressants and expectorants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands S01F Mydriatics and cycloplegics 2024* 0.18
Total male and female 0 to 64 years, standardised Origin: born in the Netherlands S01G Decongestants and antiallergics 2024* 1.40
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A Alimentary tract and metabolism 2024* 13.92
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A02B Drugs for peptic ulcer and gord 2024* 6.02
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A03B Belladonna and derivatives, plain 2024* 0.02
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A03E Antispasmodics and anticholinergics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A04 Antiemetics and antinauseants 2024* 0.70
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A04A Antiemetics and antinauseants 2024* 0.70
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A05 Bile and liver therapy 2024* 0.08
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A05C Bile therapy drugs and lipotropics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A10A Insulins and analogues 2024* 0.84
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A11C Vit A and D, incl.combin.of the two 2024* 0.06
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A11D Vitamin B1,and with vit. B6 and B12 2024* 0.01
Total male and female 0 to 64 years, standardised Origin country: The Netherlands A16A Oth.aliment.tract and metabol.prod. 2024* 0.02
Total male and female 0 to 64 years, standardised Origin country: The Netherlands B Blood and blood forming organs 2024* 6.30
Total male and female 0 to 64 years, standardised Origin country: The Netherlands B02B Vitamin k and other hemostatics 2024* 0.03
Total male and female 0 to 64 years, standardised Origin country: The Netherlands B03B Vitamin B12 and folic acid 2024* 1.20
Total male and female 0 to 64 years, standardised Origin country: The Netherlands B05A Blood and related products 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands B05Z Hemodialytics and hemofiltrates 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands C01B Antiarrhythmics, class I and III 2024* 0.14
Total male and female 0 to 64 years, standardised Origin country: The Netherlands C07B Beta blocking agents and thiazides 2024* 0.02
Total male and female 0 to 64 years, standardised Origin country: The Netherlands D02 Emollients and protectives 2024* 5.28
Total male and female 0 to 64 years, standardised Origin country: The Netherlands D02A Emollients and protectives 2024* 5.28
Total male and female 0 to 64 years, standardised Origin country: The Netherlands D08 Antiseptics and disinfectants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands D08A Antiseptics and disinfectants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands G Genito urinary system and sex hormones 2024* 6.29
Total male and female 0 to 64 years, standardised Origin country: The Netherlands G03B Androgens 2024* 0.17
Total male and female 0 to 64 years, standardised Origin country: The Netherlands G03E Androgens / female sex hormon.comb. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands G03H Antiandrogens 2024* 0.01
Total male and female 0 to 64 years, standardised Origin country: The Netherlands H05A Parathyroid hormones and analogues 2024* 0.01
Total male and female 0 to 64 years, standardised Origin country: The Netherlands J01E Sulfonamides and trimethoprim 2024* 0.60
Total male and female 0 to 64 years, standardised Origin country: The Netherlands J06 Immune sera and immunoglobulins 2024* 0.05
Total male and female 0 to 64 years, standardised Origin country: The Netherlands J07C Bacterial and viral vaccines,combi. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands L Antineoplastic and immunomodul. agents 2024* 1.35
Total male and female 0 to 64 years, standardised Origin country: The Netherlands L01F Monoclonal antbodies and a.d.c. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands L02A Hormones and related agents 2024* 0.11
Total male and female 0 to 64 years, standardised Origin country: The Netherlands M02A Joint and muscular pain top. prod. 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands M05B Bone structure and mineralization . 2024* 0.36
Total male and female 0 to 64 years, standardised Origin country: The Netherlands N02B Other analgesics and antipyretics 2024* 0.76
Total male and female 0 to 64 years, standardised Origin country: The Netherlands N05C Hypnotics and sedatives 2024* 0.83
Total male and female 0 to 64 years, standardised Origin country: The Netherlands P01C Leishmaniasis and trypanosomiasis 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands P03B Insecticides and repellents 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands R05 Cough and cold preparations 2024* 2.24
Total male and female 0 to 64 years, standardised Origin country: The Netherlands R05F Cough suppressants and expectorants 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: The Netherlands S01F Mydriatics and cycloplegics 2024* 0.16
Total male and female 0 to 64 years, standardised Origin country: The Netherlands S01G Decongestants and antiallergics 2024* 1.30
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A Alimentary tract and metabolism 2024* 15.47
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A02B Drugs for peptic ulcer and gord 2024* 6.01
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A03B Belladonna and derivatives, plain 2024* 0.02
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A03E Antispasmodics and anticholinergics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A04 Antiemetics and antinauseants 2024* 0.76
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A04A Antiemetics and antinauseants 2024* 0.76
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A05 Bile and liver therapy 2024* 0.11
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A05C Bile therapy drugs and lipotropics 2024* 0.00
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A10A Insulins and analogues 2024* 1.28
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A11C Vit A and D, incl.combin.of the two 2024* 0.17
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A11D Vitamin B1,and with vit. B6 and B12 2024* 0.01
Total male and female 0 to 64 years, standardised Origin country: Dutch Caribbean A16A Oth.aliment.tract and metabol.prod. 2024* 0.01
Source: CBS.
Explanation of symbols

Table explanation


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, origin, age and sex.

Data available from 2020

Status of the figures:
Figures for 2024 are provisional, figures for previous years are final.

Changes as of December 18, 2025:
- Provisional figures for 2024 have been added, provisional figures of 2023 have been made definite.
- Figures for 2024 do not include DDD's as they are insufficiently reliable.

When will new figures be published?
New figures will be published in the last quarter of 2026.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.